ImmuPharma plc (LON:IMM – Get Free Report) was up 0.9% during trading on Friday . The company traded as high as GBX 7.68 and last traded at GBX 6.70. Approximately 245,650 shares were traded during trading, a decline of 93% from the average daily volume of 3,335,700 shares. The stock had previously closed at GBX 6.64.
ImmuPharma Trading Up 0.9%
The stock has a market capitalization of £33.68 million, a P/E ratio of -7.53 and a beta of 3.02. The stock’s fifty day moving average price is GBX 7.15 and its two-hundred day moving average price is GBX 8.24.
ImmuPharma Company Profile
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
See Also
- Five stocks we like better than ImmuPharma
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
